Investors

Date	Name	Title	Type	Shares Traded	Price Range
Jan 22, 2008	goldstein joseph l	Director	Option Execute	5,000	7.66
Mar 26, 2012	goldstein joseph l	Director	Automatic Sell	5,000	120.00
Mar 26, 2012	goldstein joseph l	Director	Option Execute	5,000	18.61
Jan 4, 2013	goldstein joseph l	Director	Automatic Sell	5,000	180.50 - 181.22
Jan 4, 2013	goldstein joseph l	Director	Option Execute	5,000	33.42
Jan 9, 2013	goldstein joseph l	Director	Automatic Sell	5,000	185.00
Jan 9, 2013	goldstein joseph l	Director	Option Execute	5,000	57.11
Apr 1, 2013	goldstein joseph l	Director	Automatic Sell	5,000	180.00
Apr 1, 2013	goldstein joseph l	Director	Option Execute	5,000	24.41
Dec 17, 2012	mccorkle douglas s	Officer	Option Execute	5,000	16.80
May 13, 2010	shooter eric m	Director	Option Execute	5,000	25.43
May 18, 2010	sing george l	Director	Buy	5,000	28.44
Jun 9, 2010	sing george l	Director	Option Execute	5,000	25.43
Nov 29, 2012	sing george l	Director	Sell	5,000	185.00
Nov 16, 2012	sing george l	Director	Sell	5,000	152.00
Aug 22, 2012	sing george l	Director	Sell	5,000	139.00
Aug 23, 2012	sing george l	Director	Sell	5,000	142.00
Aug 22, 2012	sing george l	Director	Option Execute	5,000	18.80
Aug 23, 2012	sing george l	Director	Option Execute	5,000	18.80
Jul 26, 2012	sing george l	Director	Sell	5,000	135.00
Showing 161-180 of 633 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.